FR23C1040I1 - Combinaison comprenant un cristal stable d'un composé 4-oxoquinoline - Google Patents

Combinaison comprenant un cristal stable d'un composé 4-oxoquinoline

Info

Publication number
FR23C1040I1
FR23C1040I1 FR23C1040C FR23C1040C FR23C1040I1 FR 23C1040 I1 FR23C1040 I1 FR 23C1040I1 FR 23C1040 C FR23C1040 C FR 23C1040C FR 23C1040 C FR23C1040 C FR 23C1040C FR 23C1040 I1 FR23C1040 I1 FR 23C1040I1
Authority
FR
France
Prior art keywords
combination
stable crystal
oxoquinoline compound
oxoquinoline
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR23C1040C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35079161&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR23C1040(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of FR23C1040I1 publication Critical patent/FR23C1040I1/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR23C1040C 2004-05-20 2023-11-02 Combinaison comprenant un cristal stable d'un composé 4-oxoquinoline Active FR23C1040I1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004150979 2004-05-20
EP12173572A EP2514746A1 (en) 2004-05-20 2005-05-19 Stable crystal of 4-oxoquinoline compound
EP05726243A EP1636190B1 (en) 2004-05-20 2005-05-19 Stable crystal of 4-oxoquinoline compound
PCT/JP2005/009604 WO2005113508A1 (en) 2004-05-20 2005-05-19 Stable crystal of 4-oxoquinoline compound

Publications (1)

Publication Number Publication Date
FR23C1040I1 true FR23C1040I1 (fr) 2023-12-29

Family

ID=35079161

Family Applications (1)

Application Number Title Priority Date Filing Date
FR23C1040C Active FR23C1040I1 (fr) 2004-05-20 2023-11-02 Combinaison comprenant un cristal stable d'un composé 4-oxoquinoline

Country Status (34)

Country Link
US (6) US7635704B2 (pt)
EP (4) EP1636190B1 (pt)
JP (1) JP3754064B2 (pt)
KR (1) KR20080064909A (pt)
CN (1) CN1956961B (pt)
AR (2) AR049280A1 (pt)
AU (1) AU2005245296B2 (pt)
BE (1) BE2024C511I2 (pt)
BR (1) BRPI0510114B8 (pt)
CA (1) CA2566922C (pt)
CY (1) CY1113010T1 (pt)
DK (2) DK3281939T3 (pt)
ES (2) ES2388441T3 (pt)
FI (2) FI3281939T3 (pt)
FR (1) FR23C1040I1 (pt)
HK (1) HK1083341A1 (pt)
HR (2) HRP20231588T3 (pt)
HU (2) HUE064615T2 (pt)
IL (1) IL179250A0 (pt)
LT (1) LT3281939T (pt)
LU (1) LUC00334I2 (pt)
MX (1) MXPA06013405A (pt)
MY (1) MY134672A (pt)
NO (6) NO339223B1 (pt)
NZ (1) NZ551839A (pt)
PE (2) PE20120361A1 (pt)
PL (2) PL1636190T3 (pt)
PT (2) PT3281939T (pt)
RS (2) RS52375B (pt)
RU (1) RU2330845C1 (pt)
SI (2) SI1636190T1 (pt)
TW (1) TWI329015B (pt)
WO (1) WO2005113508A1 (pt)
ZA (1) ZA200610647B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6891227B2 (en) 2002-03-20 2005-05-10 International Business Machines Corporation Self-aligned nanotube field effect transistor and method of fabricating same
CA2470365C (en) * 2002-11-20 2011-05-17 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
MY134672A (en) * 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
WO2007063869A1 (ja) * 2005-11-30 2007-06-07 Japan Tobacco Inc. 高純度キノロン化合物の製造方法
AU2013203476C1 (en) * 2005-12-30 2016-11-17 Gilead Sciences, Inc. Methods for improving the pharmacokinetics of hiv integrase inhibitors
EP2308490A1 (en) * 2005-12-30 2011-04-13 Gilead Sciences, Inc. Methods for improving the pharmacokinetics of hiv integrase inhibitors
US20090233964A1 (en) * 2005-12-30 2009-09-17 Gilead Sciences, Inc. Methods for improving the pharmacokinetics of hiv integrase inhibitors
US20090018162A1 (en) * 2006-02-01 2009-01-15 Yuji Matsuzaki Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection
WO2007092802A1 (en) * 2006-02-09 2007-08-16 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and gs 9137
CN101437801B (zh) 2006-03-06 2013-02-06 日本烟草产业株式会社 制备4-氧代喹啉化合物的方法
ES2531190T3 (es) 2006-03-06 2015-03-11 Japan Tobacco Inc Método para producir un compuesto de 4-oxoquinolina
EP2049506B2 (en) 2006-07-07 2024-05-08 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
TWI411602B (zh) 2006-09-12 2013-10-11 Gilead Sciences Inc 製造整合酶抑制劑的方法及彼所用的中間物
LT2487166T (lt) * 2007-02-23 2016-11-10 Gilead Sciences, Inc. Terapinių agentų farmakokinetinių savybių moduliatoriai
WO2009006203A1 (en) * 2007-06-29 2009-01-08 Gilead Sciences, Inc. Therapeutic compositions and the use thereof
JP5547066B2 (ja) * 2007-06-29 2014-07-09 ギリアード サイエンシーズ， インコーポレイテッド 治療用組成物およびその使用
AR068403A1 (es) 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa
SG190618A1 (en) 2008-05-02 2013-06-28 Gilead Sciences Inc The use of solid carrier particles to improve the processability of a pharmaceutical agent
SG10201706215UA (en) 2009-02-06 2017-08-30 Gilead Sciences Inc Tablets for combination therapy
WO2010137032A2 (en) * 2009-05-14 2010-12-02 Matrix Laboratories Ltd. Novel polymorphic forms of elvitegravir and its pharmaceutically acceptable salts
WO2011004389A2 (en) * 2009-06-18 2011-01-13 Matrix Laboratories Ltd An improved process for the preparation of elvitegravir
CN102212032B (zh) * 2011-04-20 2013-07-31 复旦大学 一种5-羟基喹诺酮类衍生物及其制备方法和用途
WO2014008458A2 (en) 2012-07-06 2014-01-09 Genentech, Inc. N-substituted benzamides and methods of use thereof
ES2608860T3 (es) 2012-08-03 2017-04-17 Gilead Sciences, Inc. Proceso e intermedios para preparar inhibidores de la integrasa
CN103819402B (zh) * 2012-11-17 2016-03-30 上海迪赛诺化学制药有限公司 埃替拉韦中间体及其制备方法和应用
CN103864682B (zh) * 2012-12-18 2016-12-28 上海迪赛诺化学制药有限公司 一种制备iii型埃替拉韦晶体的方法
ES2926068T3 (es) 2012-12-21 2022-10-21 Gilead Sciences Inc Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico
PT3252058T (pt) 2013-07-12 2021-03-09 Gilead Sciences Inc Compostos policíclicos-carbamoílpiridona e seu uso para o tratamento de infecções por hiv
NO2865735T3 (pt) 2013-07-12 2018-07-21
CN105315203A (zh) * 2014-06-06 2016-02-10 上海迪赛诺化学制药有限公司 一种v型埃替拉韦晶体及其制备方法
NO2717902T3 (pt) 2014-06-20 2018-06-23
TWI677489B (zh) 2014-06-20 2019-11-21 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
TWI738321B (zh) 2014-12-23 2021-09-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
ES2837383T3 (es) 2015-04-02 2021-06-30 Gilead Sciences Inc Compuestos de carbamoilpiridonas policíclicos y su utilización farmacéutica
CN106008195B (zh) * 2016-05-19 2018-08-03 绍兴文理学院 一种2，4-二氟-5-碘苯甲酸的制备方法
EP3984536A1 (en) * 2020-10-19 2022-04-20 Centre national de la recherche scientifique Inhibition of the hiv-1 replication by compounds directed against a new target of the viral cycle

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472859A (en) * 1966-11-01 1969-10-14 Sterling Drug Inc 1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters
JPS567162B1 (pt) 1970-09-14 1981-02-16
JPS4826772A (pt) 1971-08-11 1973-04-09
JPS6450979A (en) 1987-08-21 1989-02-27 Hitachi Shipbuilding Eng Co Method for discriminating whistle sound
JPH0651229B2 (ja) 1989-07-31 1994-07-06 新日本製鐵株式会社 プラズマアーク溶接方法および装置
IL100555A (en) 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
JP2993316B2 (ja) 1992-05-27 1999-12-20 宇部興産株式会社 アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤
JPH06199835A (ja) 1993-01-08 1994-07-19 Hokuriku Seiyaku Co Ltd ８−ジフルオロメトキシキノリン−３−カルボン酸誘導体
JPH06271568A (ja) 1993-03-22 1994-09-27 Hokuriku Seiyaku Co Ltd ７−フェニルピペラジニルキノリン−３−カルボン酸誘導体
JP2930539B2 (ja) 1994-07-18 1999-08-03 三共株式会社 トリフルオロメチルキノリンカルボン酸誘導体
MX9700497A (es) * 1994-07-18 1997-04-30 Ube Industries Derivado de acido trifluorometilquinolinocarboxilico.
JPH0826772A (ja) 1994-07-22 1996-01-30 Sony Corp 融着用ガラス、その製造方法及び製造装置、並びに磁気ヘッドの製造方法
AU725629B2 (en) 1996-04-12 2000-10-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Acridone-derived compounds useful as antineoplastic and antiretroviral agents
FR2761687B1 (fr) * 1997-04-08 2000-09-15 Centre Nat Rech Scient Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
JP3776203B2 (ja) 1997-05-13 2006-05-17 第一製薬株式会社 Ｉｃａｍ−１産生阻害剤
GB9721964D0 (en) * 1997-10-16 1997-12-17 Pfizer Ltd Isoquinolines
US6399629B1 (en) 1998-06-01 2002-06-04 Microcide Pharmaceuticals, Inc. Efflux pump inhibitors
US6248739B1 (en) 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
US6248736B1 (en) 1999-01-08 2001-06-19 Pharmacia & Upjohn Company 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
PE20011349A1 (es) * 2000-06-16 2002-01-19 Upjohn Co 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
AU2002230392A1 (en) 2000-10-12 2002-05-15 Merck & Co., Inc. AZA-and polyaza-naphthalenyl ketones useful as HIV integrase inhibitors
AU2002246499B2 (en) 2000-10-12 2005-12-22 Merck & Co., Inc. Aza-and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors
HUP0400175A2 (en) * 2001-03-01 2007-07-30 Shionogi & Co Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity, their use and pharmaceutical compositions containing them
JP2002293745A (ja) 2001-03-29 2002-10-09 St Marianna Univ School Of Medicine 慢性関節リウマチ治療剤
US20030138483A1 (en) * 2001-05-25 2003-07-24 Sergio Petriconi Soft elastic capsules and compositions thereof
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs
FR2827600A1 (fr) 2001-07-20 2003-01-24 Lipha Derives acides de quinolone et leurs applications en therapeutique
JP4035765B2 (ja) 2002-10-31 2008-01-23 横河電機株式会社 フーリエ変換型赤外線分光計
JP3567162B1 (ja) 2002-11-20 2004-09-22 日本たばこ産業株式会社 ４−オキソキノリン化合物及びそのｈｉｖインテグラーゼ阻害剤としての利用
CA2470365C (en) * 2002-11-20 2011-05-17 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
MY134672A (en) * 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
US7531554B2 (en) * 2004-05-20 2009-05-12 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as HIV integrase inhibitor
JP4629104B2 (ja) * 2004-05-21 2011-02-09 日本たばこ産業株式会社 ４−オキソキノリン誘導体および抗ｈｉｖ剤を含む併用剤

Also Published As

Publication number Publication date
IL179250A0 (en) 2007-03-08
JP3754064B2 (ja) 2006-03-08
HRP20231588T3 (hr) 2024-03-15
US20150361044A1 (en) 2015-12-17
CA2566922C (en) 2011-01-11
CA2566922A1 (en) 2005-12-01
CY1113010T1 (el) 2016-04-13
PL1636190T3 (pl) 2012-10-31
BRPI0510114B8 (pt) 2021-05-25
RS52375B (en) 2012-12-31
FI3281939T3 (fi) 2023-10-23
DK1636190T3 (da) 2012-09-24
NO347902B1 (no) 2024-05-06
US20100204271A1 (en) 2010-08-12
TW200600097A (en) 2006-01-01
PL3281939T3 (pl) 2024-03-18
PT3281939T (pt) 2023-11-22
NO20230913A1 (no) 2007-02-07
US20190185433A1 (en) 2019-06-20
SI1636190T1 (sl) 2012-09-28
US20220235009A1 (en) 2022-07-28
NO339223B1 (no) 2016-11-21
FIC20240008I1 (fi) 2024-03-20
EP3281939B1 (en) 2023-10-18
BRPI0510114B1 (pt) 2020-09-15
EP1636190A1 (en) 2006-03-22
AU2005245296B2 (en) 2010-08-12
ES2388441T3 (es) 2012-10-15
ES2960824T3 (es) 2024-03-06
LUC00334I2 (pt) 2024-07-01
HUE064615T2 (hu) 2024-04-28
US20060030710A1 (en) 2006-02-09
NO20190051A1 (no) 2007-02-07
SI3281939T1 (sl) 2024-02-29
NZ551839A (en) 2009-11-27
TWI329015B (en) 2010-08-21
EP3281939A1 (en) 2018-02-14
HK1083341A1 (en) 2006-06-30
NO20065790L (no) 2007-02-07
CN1956961A (zh) 2007-05-02
AU2005245296A1 (en) 2005-12-01
EP4299563A3 (en) 2024-02-28
RU2330845C1 (ru) 2008-08-10
ZA200610647B (en) 2008-06-25
BRPI0510114A (pt) 2007-09-25
CN1956961B (zh) 2010-05-26
US20180029989A1 (en) 2018-02-01
EP1636190B1 (en) 2012-06-27
EP2514746A1 (en) 2012-10-24
EP4299563A2 (en) 2024-01-03
NO20161297A1 (no) 2007-02-07
KR20080064909A (ko) 2008-07-09
DK3281939T3 (da) 2024-01-22
NO20220690A1 (no) 2007-02-07
PE20120361A1 (es) 2012-05-03
WO2005113508A1 (en) 2005-12-01
US7635704B2 (en) 2009-12-22
PE20060358A1 (es) 2006-05-12
AR049280A1 (es) 2006-07-12
NO20200873A1 (no) 2007-02-07
US8981103B2 (en) 2015-03-17
HRP20120681T1 (hr) 2012-09-30
MY134672A (en) 2007-12-31
MXPA06013405A (es) 2007-03-01
PT1636190E (pt) 2012-08-20
HUS2400006I1 (hu) 2024-04-28
RS64845B1 (sr) 2023-12-29
JP2006001927A (ja) 2006-01-05
AR096100A2 (es) 2015-12-09
BE2024C511I2 (pt) 2024-10-08
LT3281939T (lt) 2023-11-27

Similar Documents

Publication Publication Date Title
FR23C1040I1 (fr) Combinaison comprenant un cristal stable d'un composé 4-oxoquinoline
DE50309032D1 (de) Fungizide wirkstoffkombinationen
DK3061467T3 (da) Sårforbinding med en bakterieadsorberende sammensætning
DE50309693D1 (de) Fungizide wirkstoffkombination
DE602005015215D1 (de) Orthosubstituierte aryl- oder heteroarylamidverbindungen
DK1817309T3 (da) Acetamidforbindelser som fungicider
ZA200708811B (en) Use of a sulfonamide compound for improving the pharma-cokinetics of a drug
DE602005018653D1 (de) Aktive auswahl der bestätigungsquelle
NO20080412L (no) Ny fysiologisk forbindelse Nesfatin, forbindelse relevant dertil og anvendelse av forbindelsene
DE502004010641D1 (de) Atemschutzmaske
ITUD20040054A1 (it) Procedimento per la realizzazione di un
DE502005001784D1 (de) Fungizide wirkstoffkombinationen
ITMI20040230A1 (it) Composti ad attivita' antitumorale
ITRE20040074A1 (it) "profumatore per ambienti"
FR2866666B1 (fr) About d'echafaudage
LT1802302T (lt) Lfa-simpatomimetikų, turinčių 2-imidazolino struktūra, naujas panaudojimas
ATE418990T1 (de) Pulmonäre verabreichung einer antithrombotischen verbindung
SE0400022D0 (sv) New compounds
AT501354A3 (de) Atemmaske
SE0202115D0 (sv) Use of a composition
UA10016S (uk) Скляний циферблат для настінного годинника «матрац червоний»
ITCT20040010A1 (it) S i f o n e a g r a v i t a '
FI20020094A (fi) Nefriinintapaisten yhdisteiden käyttö
ITMI20042337A1 (it) Apparecchiatura per l'applicazione di chiodi a calzature
SE0401667D0 (sv) New compounds